{"id":28275,"date":"2021-05-01T03:45:56","date_gmt":"2021-05-01T03:45:56","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=28275"},"modified":"2021-05-01T03:45:56","modified_gmt":"2021-05-01T03:45:56","slug":"astrazeneca-makes-275-million-in-sales-from-covid-vaccine","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=28275","title":{"rendered":"AstraZeneca makes $275 million in sales from Covid vaccine"},"content":{"rendered":"<p>British pharmaceuticals giant AstraZeneca reported on Friday $275 million (227 million euros) in sales from its Covid vaccine in the first three months of the year.<\/p>\n<p>It is the first time that the company discloses figures from sales of one of the world\u2019s leading vaccines.<\/p>\n<p>AstraZeneca\u2019s Covid-19 jab was developed with the University of Oxford and has been key in Britain\u2019s rapid vaccination drive. The company is selling it at cost price.<\/p>\n<p>However, public confidence in the jab has taken a blow over worries of links to very rare blood clots, and the company is in a legal fight with the EU over delivery shortfalls.<\/p>\n<p>The company made the disclosure in an earnings statement showing that net profit doubled in the first quarter to $1.56 billion, compared with $780 million a year earlier.<\/p>\n<p>Revenue jumped 15 percent \u2014 or 11 percent at constant exchange rates \u2014 to $7.32 billion in the reporting period.<\/p>\n<p>Excluding the contribution from the Covid jab, revenues rose by 11 percent \u2014 or 7.0 percent at constant rates \u2014 to $7.045 billion.<\/p>\n<p>AstraZeneca added Thursday that its quarterly performance was boosted by strong sales of new cancer drugs.<\/p>\n<p>The firm cautioned however that the Covid pandemic had a \u201cnegative impact\u201d on both the diagnosis and treatment of other conditions aside from Covid.<\/p>\n<p>\u201cWe delivered solid progress in the first quarter of 2021 and continued to advance our portfolio of life-changing medicines,\u201d said chief executive Pascal Soriot in the earnings release.<\/p>\n<p>\u201cNew medicines contributed over half of revenue and all regions delivered encouraging growth,\u201d Soriot said.<\/p>\n<p>\u201cThis performance ensured another quarter of strong revenue and earnings progression, continued profitability, and cash-flow generation, despite the pandemic\u2019s ongoing negative impact on the diagnosis and treatment of many conditions.\u201d<\/p>\n<p>The results come at the end of a turbulent week after the European Union launched legal action against AstraZeneca over Covid-19 vaccine delivery shortfalls that hampered efforts to kickstart inoculations across the bloc.<\/p>\n<p>The EU is suing AstraZeneca on the basis of breaches of an advanced purchase agreement, but the firm has dismissed the legal action \u201cwithout merit\u201d and stated that it will strongly defend itself in court.<\/p>\n<p>AstraZeneca said it is due to have delivered about 50 million doses to Europe by the end of April, but that is far lower than the amount Brussels insists should have come.<\/p>\n<p>The commission says overall the firm is set to deliver only a third of the 300 million doses it had promised by June.<\/p>\n<p>The EU-AstraZeneca court hearing has been set for May 26, a Belgian court said Wednesday.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>British pharmaceuticals giant AstraZeneca reported on Friday $275 million (227 million euros) in sales from its Covid vaccine in the first three months of the year. It is the first time that the company discloses figures from sales of one of the world\u2019s leading vaccines. AstraZeneca\u2019s Covid-19 jab was developed with the University of Oxford [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":28277,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[48,39],"tags":[],"jetpack_featured_media_url":"https:\/\/www.observerbd.com\/2021\/04\/30\/observerbd.com_1619784249.jpg","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/28275"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28275"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/28275\/revisions"}],"predecessor-version":[{"id":28276,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/28275\/revisions\/28276"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/28277"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}